Kuzuhara Takashi, Kise Daisuke, Yoshida Hiroko, Horita Takahiro, Murazaki Yoshimi, Nishimura Akie, Echigo Noriko, Utsunomiya Hiroko, Tsuge Hideaki
Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, and Institute for Health Sciences, Tokushima Bunri University, Tokushima 770-8514, Japan.
J Biol Chem. 2009 Mar 13;284(11):6855-60. doi: 10.1074/jbc.C800224200. Epub 2009 Jan 14.
Because the influenza A virus has an RNA genome, its RNA-dependent RNA polymerase, comprising the PA, PB1, and PB2 subunits, is essential for viral transcription and replication. The binding of RNA primers/promoters to the polymerases is an initiation step in viral transcription. In our current study, we reveal the 2.7 A tertiary structure of the C-terminal RNA-binding domain of PB2 by x-ray crystallography. This domain incorporates lysine 627 of PB2, and this residue is associated with the high pathogenicity and host range restriction of influenza A virus. We found from our current analyses that this lysine is located in a unique "phi"-shaped structure consisting of a helix and an encircled loop within the PB2 domain. By electrostatic analysis, we identified a highly basic groove along with this phi loop and found that lysine 627 is located in the phi loop. A PB2 domain mutant in which glutamic acid is substituted at position 627 shows significantly lower RNA binding activity. This is the first report to show a relationship between RNA binding activity and the pathogenicity-determinant lysine 627. Using the Matras program for protein three-dimensional structural comparisons, we further found that the helix bundles in the PB2 domain are similar to that of activator 1, the 40-kDa subunit of DNA replication clamp loader (replication factor C), which is also an RNA-binding protein. This suggests a functional and structural relationship between the RNA-binding mechanisms underlying both influenza A viral transcription and cellular DNA replication. Our present results thus provide important new information for developing novel drugs that target the primer/promoter RNA binding of viral RNA polymerases.
由于甲型流感病毒具有RNA基因组,其由PA、PB1和PB2亚基组成的RNA依赖性RNA聚合酶对于病毒转录和复制至关重要。RNA引物/启动子与聚合酶的结合是病毒转录的起始步骤。在我们当前的研究中,我们通过X射线晶体学揭示了PB2 C末端RNA结合结构域的2.7埃三级结构。该结构域包含PB2的赖氨酸627,并且该残基与甲型流感病毒的高致病性和宿主范围限制相关。我们从当前分析中发现,该赖氨酸位于PB2结构域内由一个螺旋和一个环绕环组成的独特“φ”形结构中。通过静电分析,我们确定了一个沿着该φ环的高度碱性凹槽,并发现赖氨酸627位于该φ环中。在627位被谷氨酸取代的PB2结构域突变体显示出明显较低的RNA结合活性。这是首次报道显示RNA结合活性与致病性决定因素赖氨酸627之间的关系。使用Matras程序进行蛋白质三维结构比较,我们进一步发现PB2结构域中的螺旋束类似于激活因子1,即DNA复制钳加载器(复制因子C)的40 kDa亚基,它也是一种RNA结合蛋白。这表明甲型流感病毒转录和细胞DNA复制背后的RNA结合机制之间存在功能和结构关系。因此,我们目前的结果为开发针对病毒RNA聚合酶引物/启动子RNA结合的新型药物提供了重要的新信息。